Seeing Is Believing

Currently out of the existing stock ratings of Glen Santangelo, 170 are a BUY (69.96%), 70 are a HOLD (28.81%), 3 are a SELL (1.23%).
Analyst Glen Santangelo, currently employed at BARCLAYS, carries an average stock price target met ratio of 58.93% that have a potential upside of 25.36% achieved within 224 days.
Glen Santangelo’s has documented 458 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Consumer Defensive, Technology sectors.
Most recent stock forecast was given on HIMS, Hims Hers Health at 18-Jun-2026.
Analyst best performing recommendations are on HIMS (HIMS HERS HEALTH).
The best stock recommendation documented was for HIMS (HIMS HERS HEALTH) at 2/25/2026. The price target of $25 was fulfilled within 14 days with a profit of $9.18 (58.03%) receiving and performance score of 41.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Feb-2018
$215
$40.04 (22.89%)
$187
2 years 11 months 23 days ago
(07-Aug-2023)
15/16 (93.75%)
$28.91 (15.54%)
636
Hold Since 27-May-2022
$190
$15.04 (8.60%)
$176
2 years 11 months 27 days ago
(03-Aug-2023)
12/12 (100%)
$-0.86 (-0.45%)
392
Buy Since 11-Oct-2022
$215
$40.04 (22.89%)
$200
2 years 11 months 27 days ago
(03-Aug-2023)
7/10 (70%)
$24.14 (12.65%)
211
Buy Since 05-Aug-2021
$220
$45.04 (25.74%)
$213
2 years 11 months 27 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
$190
$15.04 (8.60%)
2 years 11 months 27 days ago
(03-Aug-2023)
9/9 (100%)
$-0.86 (-0.45%)
440
Which stock is Glen Santangelo is most bullish on?
Which stock is Glen Santangelo is most reserved on?
What Year was the first public recommendation made by Glen Santangelo?